Skip to main content
Clinical Trials/NCT04888494
NCT04888494
Completed
Not Applicable

Enhancing Cortical-hippocampal Functional Connectivity as a Novel Means for Relieving Chronic Low Back Pain

Northwestern University1 site in 1 country16 target enrollmentJune 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Northwestern University
Enrollment
16
Locations
1
Primary Endpoint
Changes in Pain Scales
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with chronic low back pain.

Registry
clinicaltrials.gov
Start Date
June 25, 2021
End Date
February 2, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Apkar Apkarian

Director Center for Translational Pain Research, Director Center of Excellence for Chronic Pain and Drug Abuse Research, Professor of Physiology, Anesthesia, PM&R Northwestern University, Feinberg School of Medicine

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • ≥ 6 months of back pain on a daily basis;
  • male or female with no racial or ethnic restrictions;
  • 18 to 75 years old;
  • average back pain intensity \> 4/10 at study entry;
  • must be able to read, understand, and sign consent form;
  • generally healthy.

Exclusion Criteria

  • back pain with fever, chills, rheumatoid arthritis, ankylosing spondylitis, acute vertebral fractures,
  • history of tumor in the back;
  • back surgery within the past 6 months;
  • Chronic neurologic conditions, e.g., Parkinson's
  • involvement in litigation regarding back pain;
  • other severe medical diseases;
  • pregnancy;
  • positive urinary screen for any recreational drugs,
  • opioids use;
  • use of anticoagulants (low dose ASA allowed);

Outcomes

Primary Outcomes

Changes in Pain Scales

Time Frame: Pain is assessed at baseline, end of first intervention and end of the second intervention.

The endpoint will be the severity of pain measured by changes in the Numeric Rating Scale (NRS) scores before and after each stimulation round. The NRS is a pain screening tool that assesses pain severity during assessment using a 0-10 scale, where zero means "no pain" and ten means "the worst pain imaginable." Higher values indicate a worse outcome.

Secondary Outcomes

  • Changes in Hippocampal Connectivity(approximately 6 weeks - Baseline and after the end of hippocampal stimulation)

Study Sites (1)

Loading locations...

Similar Trials